{"id":3035,"date":"2018-12-17T16:52:52","date_gmt":"2018-12-17T15:52:52","guid":{"rendered":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent"},"modified":"2022-07-14T12:21:24","modified_gmt":"2022-07-14T10:21:24","slug":"patient-zero-detection-retarus-granted-europe-wide-patent","status":"publish","type":"post","link":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/","title":{"rendered":"Patient Zero Detection<sup>&reg;<\/sup>: Retarus granted Europe-wide patent"},"content":{"rendered":"<p>The European Patent Office has granted Retarus <a href=\"https:\/\/register.epo.org\/application?lng=en&amp;number=EP16150573\" rel=\"noopener noreferrer\" target=\"_blank\">a Europe-wide patent<\/a> for the Patient Zero Detection<sup>\u00ae<\/sup> technology developed by the company. The innovative approach to analyzing and recognizing harmful emails is an integral component of the comprehensive <a href=\"https:\/\/www.retarus.com\/services\/email-security\/\">E-Mail Security Services<\/a> offered by the global information logistics provider. Patient Zero Detection<sup>\u00ae<\/sup> swiftly identifies recipients of new, previously unknown, malware. This enables administrators to react more quickly and, for instance with ransomware, avert substantial financial damage to the company before it is too late.<\/p>\n<p>Extensive filtering performed by virus protection software is usually successful at blocking emails containing known malware reliably, before it has had the chance to find its way into the IT infrastructure. No virus filter, however, provides sufficient protection from targeted attacks using previously unknown or modified patterns of assault. When such malware first appears, it thus often sneaks into the company network unnoticed.<\/p>\n<div id=\"attachment_2828\" style=\"width: 1290px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/07\/martin-16zu9.jpg\" data-rel=\"lightbox-image-0\" data-rl_title=\"\" data-rl_caption=\"\" title=\"\"><img aria-describedby=\"caption-attachment-2828\" loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/07\/martin-16zu9.jpg\" alt=\"\" width=\"1280\" height=\"720\" class=\"size-full wp-image-2828\"><\/a><p id=\"caption-attachment-2828\" class=\"wp-caption-text\">Martin Hager, Founder CEO, Retarus<\/p><\/div>\n<p>\u201cThat\u2019s why we\u2019re always seeking new ways to meet the increasing security requirements of our customers,\u201d says Martin Hager, founder and CEO of Retarus. \u201cThe granting of this patent is further proof of the excellent work our development team is performing and the considerable innovative power at Retarus. At the same time, the patent is spurring us on \u2013 even after 25 years of experience in email security \u2013 to continue intensively developing our services \u2018Made in Germany\u2019.\u201d<\/p>\n<p>For further details please refer to <a href=\"https:\/\/www.retarus.com\/press\/retarus-granted-europe-wide-patent-novel-technique-for-detecting-malicious-emails\/\">our current press release<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Patent Office has granted Retarus a Europe-wide patent for the Patient Zero Detection<sup>&reg;<\/sup> technology developed by the company.<\/p>\n","protected":false},"author":14,"featured_media":3038,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_s2mail":"yes","footnotes":""},"categories":[8],"tags":[1237,354],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.0 (Yoast SEO v23.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Patient Zero Detection&reg;: Retarus granted Europe-wide patent - Retarus Corporate Blog - EN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patient Zero Detection&reg;: Retarus granted Europe-wide patent\" \/>\n<meta property=\"og:description\" content=\"The European Patent Office has granted Retarus a Europe-wide patent for the Patient Zero Detection&reg; technology developed by the company.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/\" \/>\n<meta property=\"og:site_name\" content=\"Retarus Corporate Blog - EN\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-17T15:52:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T10:21:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/12\/patient-zero-detection-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"977\" \/>\n\t<meta property=\"og:image:height\" content=\"550\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Thomas Cloer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Thomas Cloer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/\",\"url\":\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/\",\"name\":\"Patient Zero Detection&reg;: Retarus granted Europe-wide patent - Retarus Corporate Blog - EN\",\"isPartOf\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/12\/patient-zero-detection-2.jpg\",\"datePublished\":\"2018-12-17T15:52:52+00:00\",\"dateModified\":\"2022-07-14T10:21:24+00:00\",\"author\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/#\/schema\/person\/7f8954d8bf84d75cf384942c5f6cf2e5\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#primaryimage\",\"url\":\"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/12\/patient-zero-detection-2.jpg\",\"contentUrl\":\"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/12\/patient-zero-detection-2.jpg\",\"width\":977,\"height\":550},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.retarus.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient Zero Detection&reg;: Retarus granted Europe-wide patent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/#website\",\"url\":\"https:\/\/www.retarus.com\/blog\/en\/\",\"name\":\"Retarus Corporate Blog - EN\",\"description\":\"Always up to date\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.retarus.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.retarus.com\/blog\/en\/#\/schema\/person\/7f8954d8bf84d75cf384942c5f6cf2e5\",\"name\":\"Thomas Cloer\",\"url\":\"https:\/\/www.retarus.com\/blog\/en\/author\/thomasc\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Patient Zero Detection&reg;: Retarus granted Europe-wide patent - Retarus Corporate Blog - EN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/","og_locale":"en_US","og_type":"article","og_title":"Patient Zero Detection&reg;: Retarus granted Europe-wide patent","og_description":"The European Patent Office has granted Retarus a Europe-wide patent for the Patient Zero Detection&reg; technology developed by the company.","og_url":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/","og_site_name":"Retarus Corporate Blog - EN","article_published_time":"2018-12-17T15:52:52+00:00","article_modified_time":"2022-07-14T10:21:24+00:00","og_image":[{"width":977,"height":550,"url":"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/12\/patient-zero-detection-2.jpg","type":"image\/jpeg"}],"author":"Thomas Cloer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Thomas Cloer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/","url":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/","name":"Patient Zero Detection&reg;: Retarus granted Europe-wide patent - Retarus Corporate Blog - EN","isPartOf":{"@id":"https:\/\/www.retarus.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#primaryimage"},"image":{"@id":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#primaryimage"},"thumbnailUrl":"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/12\/patient-zero-detection-2.jpg","datePublished":"2018-12-17T15:52:52+00:00","dateModified":"2022-07-14T10:21:24+00:00","author":{"@id":"https:\/\/www.retarus.com\/blog\/en\/#\/schema\/person\/7f8954d8bf84d75cf384942c5f6cf2e5"},"breadcrumb":{"@id":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#primaryimage","url":"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/12\/patient-zero-detection-2.jpg","contentUrl":"https:\/\/www.retarus.com\/blog\/en\/wp-content\/uploads\/sites\/22\/2018\/12\/patient-zero-detection-2.jpg","width":977,"height":550},{"@type":"BreadcrumbList","@id":"https:\/\/www.retarus.com\/blog\/en\/patient-zero-detection-retarus-granted-europe-wide-patent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.retarus.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"Patient Zero Detection&reg;: Retarus granted Europe-wide patent"}]},{"@type":"WebSite","@id":"https:\/\/www.retarus.com\/blog\/en\/#website","url":"https:\/\/www.retarus.com\/blog\/en\/","name":"Retarus Corporate Blog - EN","description":"Always up to date","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.retarus.com\/blog\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.retarus.com\/blog\/en\/#\/schema\/person\/7f8954d8bf84d75cf384942c5f6cf2e5","name":"Thomas Cloer","url":"https:\/\/www.retarus.com\/blog\/en\/author\/thomasc\/"}]}},"_links":{"self":[{"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/posts\/3035"}],"collection":[{"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=3035"}],"version-history":[{"count":5,"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/posts\/3035\/revisions"}],"predecessor-version":[{"id":3939,"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/posts\/3035\/revisions\/3939"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/media\/3038"}],"wp:attachment":[{"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=3035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=3035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=3035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}